Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | PHGDH | O43175 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | CSF1R | P07333 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19985070 | 0.75 | TSHR (0.36) | MEN1KMT2AL3MBTL1MAPT | |
| SCHEMBL20130866 | 0.73 | FAAH (0.38) | HTTMEN1KMT2AFAAHPHGDH | |
| SCHEMBL3130771 | 0.69 | MEN1 (0.46) | HTTMEN1KMT2AFAAHPHGDH | |
| SCHEMBL15135243 | 0.69 | MEN1 (0.41) | HTTMEN1KMT2AFAAHPHGDH | |
| SCHEMBL19973259 | 0.66 | — | — | |
| SCHEMBL10393863 | 0.64 | ALDH1A1 (0.56) | HTTMEN1KMT2ALMNAL3MBTL1 | |
| SCHEMBL28312809 | 0.64 | CA4 (0.31) | — | |
| SCHEMBL8510220 | 0.62 | MEN1 (0.44) | HTTMEN1KMT2AFAAHPHGDH | |
| SCHEMBL15135156 | 0.62 | KMT2A (0.38) | HTTMEN1KMT2AFAAHPHGDH | |
| SCHEMBL236025 | 0.62 | LMNA (0.42) | HTTMEN1KMT2AFAAHPHGDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11584854-B2 | Compositions and methods for the deposition of silicon oxide films | VERSUM MATERIALS US, LLC (US) | 2023-02-21 | — | — | US | disclosed |
| US-20200308416-A1 | Compositions And Methods For The Deposition Of Silicon Oxide Films | VERSUM MATERIALS US, LLC (US) | 2020-10-01 | — | — | US | disclosed |
| US-20180127592-A1 | Compositions and Methods for the Deposition of Silicon Oxide Films | VERSUM MATERIALS US, LLC (US) | 2018-05-10 | — | — | US | disclosed |
| WO-2018053129-A1 | COMPOSITIONS AND METHODS FOR THE DEPOSITION OF SILICON OXIDE FILMS | VERSUM MATERIALS US, LLC (US) | 2018-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200308416-A1 | Compositions And Methods For The Deposition Of Silicon Oxide Films | SEPTIN9, SGMS1, SGMS2 | HTT 2490/4885MEN1 297/4885KMT2A 1162/4885 |
| US-20180127592-A1 | Compositions and Methods for the Deposition of Silicon Oxide Films | SEPTIN9, SGMS1, SGMS2 | HTT 2490/4885MEN1 297/4885KMT2A 1162/4885 |
| US-11584854-B2 | Compositions and methods for the deposition of silicon oxide films | SEPTIN9, SGMS1, SGMS2 | HTT 2490/4885MEN1 297/4885KMT2A 1162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.